Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada.
Journal Information
Journal Title: J Infect Dis
Detailed journal information not available.
Publication Details
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"genbank accession numbers for spsn a(h3n2) sequences included in ve analyses in 2016-2017 are: ky583507 -ky583727 mh216203-mh216548 (except mh216229 mh216330 mh216446)."
"Potential conflicts of interest. G. D. S. has received grants for investigator-initiated studies unrelated to influenza vaccine from Pfizer and provided paid expert testimony for the Ontario Nurses Association, the Quebec Ministry of Justice and GSK. M. K. has received research grants from Roche and Hologic for unrelated studies. S. J. D. is a content expert consultant to Johnson and Johnson (Janssen) Pharmaceuticals on a literature search for point-of-care testing for respiratory viruses. Other authors report no potential conflicts. Potential conflicts of interest."
"Financial support. This work was supported by the British Columbia Centre for Disease Control; Alberta Health; Public Health Ontario; Ministère de la Santé et des Services Sociaux du Québec; l’Institut National de Santé Publique du Québec; and the Public Health Agency of Canada (grant to D. M. S.; arrangement number 1617-HQ-000083). Financial support."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025